SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010339
Filing Date
2019-11-07
Accepted
2019-11-07 14:28:29
Documents
76
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q clvs-20190930x10qeade2e.htm   iXBRL 10-Q 2252122
2 EX-31.1 ex-31d1.htm EX-31.1 19875
3 EX-31.2 ex-31d2.htm EX-31.2 20098
4 EX-32.1 ex-32d1.htm EX-32.1 7990
5 EX-32.2 ex-32d2.htm EX-32.2 8075
  Complete submission text file 0001558370-19-010339.txt   8555049

Data Files

Seq Description Document Type Size
6 EX-101.SCH clvs-20190930.xsd EX-101.SCH 56524
7 EX-101.CAL clvs-20190930_cal.xml EX-101.CAL 86067
8 EX-101.DEF clvs-20190930_def.xml EX-101.DEF 155534
9 EX-101.LAB clvs-20190930_lab.xml EX-101.LAB 571984
10 EX-101.PRE clvs-20190930_pre.xml EX-101.PRE 373096
69 EXTRACTED XBRL INSTANCE DOCUMENT clvs-20190930x10qeade2e_htm.xml XML 1607350
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 191199826
SIC: 2834 Pharmaceutical Preparations